Mixed gonadal dysgenesis, pathogensis, and management

Area of Science:

• Reproductive Endocrinology
• Developmental Biology
• Pediatric Endocrinology

Background:

• Mixed Gonadal Dysgenesis (MGD) is a disorder of sexual development characterized by gonadal asymmetry, sex chromosomal mosaicism, and retained Mullerian ducts.
• This condition arises from developmental errors in the urogenital ridge, potentially linked to H-Y antigen abnormalities.
• These abnormalities disrupt the production of Mullerian inhibiting Substance and testosterone, leading to incomplete masculinization and Mullerian duct persistence.

Observation:

• Fourteen pediatric patients with MGD were analyzed.
• Key features include gonadal asymmetry, sex chromosomal mosaicism, and the presence of Mullerian ducts.
• The dysgenetic testis may arise from abnormal H-Y antigen expression, impacting urogenital differentiation.

Findings:

• MGD is associated with incomplete masculinization of external genitalia and retained Mullerian structures.
• The absence of a second X chromosome can result in a streak ovary alongside the dysgenetic testis.
• Neoplastic transformation, particularly Gonadoblastoma and seminoma-dysgerminomas, presents a significant risk, exceeding 50% by the third decade.

Implications:

• Surgical gonadectomy at birth and prompt external genitalia repair are advised.
• Management strategies should prioritize raising affected individuals as females.
• Continuous monitoring for neoplastic transformation is crucial throughout the patient's life.